BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3019359)

  • 1. Neutral proteases in human osteoarthritic synovium.
    Martel-Pelletier J; Cloutier JM; Pelletier JP
    Arthritis Rheum; 1986 Sep; 29(9):1112-21. PubMed ID: 3019359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral proteases in human osteoarthritic synovium: quantification and characterization.
    Martel-Pelletier J; Pelletier JP
    J Rheumatol; 1987 May; 14 Spec No():38-40. PubMed ID: 3305937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage.
    Martel-Pelletier J; Pelletier JP; Cloutier JM; Howell DS; Ghandur-Mnaymneh L; Woessner JF
    Arthritis Rheum; 1984 Mar; 27(3):305-12. PubMed ID: 6367752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of antirheumatic drugs on neutral collagenolytic proteases in human rheumatoid arthritis cartilage and synovium.
    Martel-Pelletier J; Cloutier JM; Pelletier JP
    J Rheumatol; 1988 Aug; 15(8):1198-204. PubMed ID: 3054093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradative enzyme systems in cartilage.
    Ehrlich MG; Armstrong AL; Treadwell BV; Mankin HJ
    Clin Orthop Relat Res; 1986 Dec; (213):62-8. PubMed ID: 3022974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of collagenase, other metallo-proteinases and an inhibitor (TIMP) produced by human synovium and cartilage in culture.
    Murphy G; McGuire MB; Russell RG; Reynolds JJ
    Clin Sci (Lond); 1981 Dec; 61(6):711-6. PubMed ID: 6271450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the release of proteolytic enzymes during synovium-induced cartilage breakdown in vitro and the actions of anti-inflammatory drugs.
    Crossley MJ; Hunneyball IM
    Biochem Pharmacol; 1984 Apr; 33(8):1263-71. PubMed ID: 6324820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis.
    Pelletier JP; Martel-Pelletier J; Ghandur-Mnaymneh L; Howell DS; Woessner JF
    Arthritis Rheum; 1985 May; 28(5):554-61. PubMed ID: 2988573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cartilage degradation by neutral proteoglycanases in experimental osteoarthritis. Suppression by steroids.
    Pelletier JP; Martel-Pelletier J
    Arthritis Rheum; 1985 Dec; 28(12):1393-401. PubMed ID: 3910049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of dipeptidyl peptidase II, dipeptidyl peptidase IV, prolyl endopeptidase, and collagenase-like peptidase in synovial membrane from patients with rheumatoid arthritis and osteoarthritis.
    Kamori M; Hagihara M; Nagatsu T; Iwata H; Miura T
    Biochem Med Metab Biol; 1991 Apr; 45(2):154-60. PubMed ID: 1679339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and histological changes in osteoarthritic synovial membrane.
    Gedikoglu O; Bayliss MT; Ali SY; Tuncer I
    Ann Rheum Dis; 1986 Apr; 45(4):289-92. PubMed ID: 3707218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis.
    Pelletier JP; Mineau F; Faure MP; Martel-Pelletier J
    Arthritis Rheum; 1990 Oct; 33(10):1466-76. PubMed ID: 2171538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of collagenase and inhibitor (TIMP) by normal, rheumatoid and osteoarthritic synovium in vitro: effects of hydrocortisone and indomethacin.
    McGuire MB; Murphy G; Reynolds JJ; Russell RG
    Clin Sci (Lond); 1981 Dec; 61(6):703-10. PubMed ID: 6271449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteoglycan-degrading acid metalloprotease activity in human osteoarthritic cartilage, and the effect of intraarticular steroid injections.
    Pelletier JP; Martel-Pelletier J; Cloutier JM; Woessner JF
    Arthritis Rheum; 1987 May; 30(5):541-8. PubMed ID: 3297073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradative enzyme systems in osteoarthritic cartilage.
    Ehrlich MG
    J Orthop Res; 1985; 3(2):170-84. PubMed ID: 2987465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tenidap on canine experimental osteoarthritis. I. Morphologic and metalloprotease analysis.
    Fernandes JC; Martel-Pelletier J; Otterness IG; Lopez-Anaya A; Mineau F; Tardif G; Pelletier JP
    Arthritis Rheum; 1995 Sep; 38(9):1290-303. PubMed ID: 7575725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid, neutral, and alkaline hydrolases in arthritic synovium.
    Kar NC; Cracchiolo A; Mirra J; Pearson CM
    Am J Clin Pathol; 1976 Feb; 65(2):220-8. PubMed ID: 3109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
    Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
    Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin B and cysteine protease inhibitors in human osteoarthritis.
    Martel-Pelletier J; Cloutier JM; Pelletier JP
    J Orthop Res; 1990 May; 8(3):336-44. PubMed ID: 2324852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.